Agenus
AGEN
#9247
Rank
A$0.17 B
Marketcap
A$4.22
Share price
-8.31%
Change (1 day)
-46.86%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): A$27.43 Million

According to Agenus 's latest financial reports the company's current earnings are A$0.10 Billion. In 2024 the company made an earning of -A$0.17 Billion, an increase over its 2023 earnings that were of -A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$27.43 M-116.92%
2024 -A$0.17 Billion-28.13%
2023 -A$0.23 Billion-5.5%
2022 -A$0.24 Billion-556.26%
2021 A$52.32 M-130.37%
2020 -A$0.18 Billion73.75%
2019 -A$99.17 Million-48.74%
2018 -A$0.2 Billion34.32%
2017 -A$0.15 Billion-7.16%
2016 -A$0.16 Billion26.55%
2015 -A$0.13 Billion110.24%
2014 -A$58.32 Million49.12%
2013 -A$39.11 Million
2011 -A$27 Million-12.25%
2010 -A$30.77 Million-21.41%
2009 -A$39.16 Million-26.86%
2008 -A$53.54 Million13.72%
2007 -A$47.08 Million-33.4%
2006 -A$70.68 Million-31.84%
2005 -A$0.11 Billion9.74%
2004 -A$94.49 Million-0.8%
2003 -A$95.26 Million17.37%
2002 -A$81.16 Million37.83%
2001 -A$58.89 Million55.99%
2000 -A$37.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.74 B 125,627.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.60 B 63,550.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.57 B 46,345.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.16 B 48,350.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-A$0.41 Billion-1,490.73%๐Ÿ‡บ๐Ÿ‡ธ USA